![Strategic Efficiencies: Evaluating Cost-Effectiveness of Biomarker-Based HCC Surveillance Strategic Efficiencies Evaluating Cost Effectiveness of Biomarker Based HCC Surveillance featured image Strategic Efficiencies Evaluating Cost Effectiveness of Biomarker Based HCC Surveillance featured image](https://clinicalvalue.com/wp-content/uploads/2024/08/Strategic-Efficiencies_-Evaluating-Cost-Effectiveness-of-Biomarker-Based-HCC-Surveillance-featured-image.png)
Recent Articles
![Strategic Efficiencies: Evaluating Cost-Effectiveness of Biomarker-Based HCC Surveillance Strategic Efficiencies Evaluating Cost Effectiveness of Biomarker Based HCC Surveillance featured image Strategic Efficiencies Evaluating Cost Effectiveness of Biomarker Based HCC Surveillance featured image](https://clinicalvalue.com/wp-content/uploads/2024/08/Strategic-Efficiencies_-Evaluating-Cost-Effectiveness-of-Biomarker-Based-HCC-Surveillance-featured-image.png)
![A Bold Stride Forward for Liver Health: Thailand's Nationwide HBV Screening and EZ Liver Clinic Final thumbnail Headshot of Dr. Passakorn Wanchaijiraboon (left) and Prof. Pisit Tangkijvanich (right)](https://clinicalvalue.com/wp-content/uploads/2024/06/Final-thumbnail.png)
A Bold Stride Forward for Liver Health: Thailand’s Nationwide HBV Screening and EZ Liver Clinic
![No woman left behind: Increasing access to testing for cervical cancer elimination No woman left behind Increasing access to testing for cervical cancer elimination featured image No woman left behind Increasing access to testing for cervical cancer elimination featured image](https://clinicalvalue.com/wp-content/uploads/2024/05/No-woman-left-behind_-Increasing-access-to-testing-for-cervical-cancer-elimination-featured-image.png)
No woman left behind: Increasing access to testing for cervical cancer elimination
![Advancing women’s health: Project Teal drives cervical cancer screening in Hong Kong Advancing womens health Project Teal drives cervical cancer screening in Hong Kong featured image Advancing womens health Project Teal drives cervical cancer screening in Hong Kong featured image](https://clinicalvalue.com/wp-content/uploads/2024/05/Advancing-womens-health_-Project-Teal-drives-cervical-cancer-screening-in-Hong-Kong-featured-image.png)
Advancing women’s health: Project Teal drives cervical cancer screening in Hong Kong
![Can Malaysia eliminate cervical cancer with this technique? Can Malaysia eliminate cervical cancer with this technique featured image Can Malaysia eliminate cervical cancer with this technique featured image](https://clinicalvalue.com/wp-content/uploads/2024/05/Can-Malaysia-eliminate-cervical-cancer-with-this-technique_-featured-image.png)
![Turning the Tide Against Hep B and HCC: Insights from New Zealand's National Screening and Surveillance Program NZ LEAP banner NZ LEAP banner](https://clinicalvalue.com/wp-content/uploads/2024/04/NZ-LEAP-banner.png)
Turning the Tide Against Hep B and HCC: Insights from New Zealand’s National Screening and Surveillance Program
![The Pursuit for Better Patient Outcomes - Innovating HCC Management at Siriraj Hospital Siriraj Hospital Siriraj Hospital](https://clinicalvalue.com/wp-content/uploads/2024/02/Siriraj-Hospital-1280x720.jpg)
The Pursuit for Better Patient Outcomes – Innovating HCC Management at Siriraj Hospital
![Value and Challenges for Precision Oncology Realisation in Real World Practice Screenshot 2023 11 07 112351 Screenshot 2023 11 07 112351](https://clinicalvalue.com/wp-content/uploads/2023/11/Screenshot-2023-11-07-112351-1280x720.jpg)
Value and Challenges for Precision Oncology Realisation in Real World Practice
In this interview, Prof Chiu discusses the value of NGS testing to identify lung cancer driver mutations to detect and treat lung cancer early. He also…
READ MORE![HCC monitoring and surveillance update - the limbic HCC monitoring and surveillance udpate resize HCC monitoring and surveillance udpate resize](https://clinicalvalue.com/wp-content/uploads/2023/11/HCC-monitoring-and-surveillance-udpate-resize.png)
![Advancing Liver Health Ecosystem for Improve Patient Outcomes: A Hong Kong Perspective DSC00485 1 DSC00485 1](https://clinicalvalue.com/wp-content/uploads/2023/09/DSC00485-1-1280x755.jpg)
Advancing Liver Health Ecosystem for Improve Patient Outcomes: A Hong Kong Perspective
In this interview with Prof Yuen, Chief of Division of Gastroenterology and Hepatology in the University of Hong Kong, explore Hong Kong's current liver health ecosystem,…
READ MORE![NGS and precision oncology in Australia: insights from Profs Peter Gibbs and Svetlana Cherepanoff New Project 3 New Project 3](https://clinicalvalue.com/wp-content/uploads/2023/08/New-Project-3.png)
NGS and precision oncology in Australia: insights from Profs Peter Gibbs and Svetlana Cherepanoff
In this article, Prof Peter Gibbs and Prof Svetlana Cherepanoff discuss the issues surrounding the clinical integration of NGS in Australia.
READ MORE![NGS and precision oncology in Taiwan: insights from Dr Jan-Gowth Chang and Dr Jason CH Hsieh New Project 7 New Project 7](https://clinicalvalue.com/wp-content/uploads/2023/08/New-Project-7.png)
NGS and precision oncology in Taiwan: insights from Dr Jan-Gowth Chang and Dr Jason CH Hsieh
NGS and digital applications for oncology management can help improve early cancer detection and prevention, reducing human and economic costs of the cancer. In this article,…
READ MORE![NGS and precision oncology in India: insights from Dr Amit Rauthan New Project 6 New Project 6](https://clinicalvalue.com/wp-content/uploads/2023/08/New-Project-6.png)
NGS and precision oncology in India: insights from Dr Amit Rauthan
In this article, Dr Amit Rauthan shares insights on the challenges and opportunities for greater NGS adoption in India.
READ MORE![Leading the Way for HCC Surveillance and Diagnosis: Prof. Henry LY Chan Prof Chan 1 Prof Chan 1](https://clinicalvalue.com/wp-content/uploads/2023/06/Prof-Chan-1-1280x854.png)
Leading the Way for HCC Surveillance and Diagnosis: Prof. Henry LY Chan
In this video, Prof Henry LY Chan, Deputy Chief Manager at Union Hospital Hong Kong, discusses how PIVKA-II can complement AFP and Ultrasound in assisting clinicians…
READ MORE![Moving towards risk-based surveillance and early detection of hepatocellular carcinoma EASL 2023 EASL 2023](https://clinicalvalue.com/wp-content/uploads/2023/05/EASL-2023-1280x648.jpg)
Moving towards risk-based surveillance and early detection of hepatocellular carcinoma
![NGS and precision oncology in Hong Kong: insights from Dr Lam Tai-Chung New Project 6 New Project 6](https://clinicalvalue.com/wp-content/uploads/2023/05/New-Project-6.png)
NGS and precision oncology in Hong Kong: insights from Dr Lam Tai-Chung
In this article, Dr Lam Tai-Chung shares how his institution has had first-hand experience of landmark cases and outstanding treatment responses from using NGS in seemingly…
READ MORE![Next-generation sequencing (NGS) drives precision oncology in Singapore New Project 5 New Project 5](https://clinicalvalue.com/wp-content/uploads/2023/05/New-Project-5.png)
Next-generation sequencing (NGS) drives precision oncology in Singapore
In this article, Dr David Tan discusses the potential of NGS in Singapore, where the adoption of this technology is only just beginning to take root.
READ MORE![NGS and precision oncology in South Korea: insights from Prof Kim Jee-Hyun New Project 7 Headshot of Prof Kim Jee-Hyun](https://clinicalvalue.com/wp-content/uploads/2023/05/New-Project-7.png)
NGS and precision oncology in South Korea: insights from Prof Kim Jee-Hyun
In this article, Prof Jee Hyun Kim explains her clinical experiences of NGS, and how she sees it evolving within South Korea’s innovative healthcare ecosystem.
READ MORE![Breaking barriers to precision oncology implementation with digital solutions roche ht article digital solutions enabling precision oncology 1440x450 1 roche ht article digital solutions enabling precision oncology 1440x450 1](https://clinicalvalue.com/wp-content/uploads/2023/05/roche-ht-article-digital-solutions-enabling-precision-oncology-1440x450-1-1280x400.png)
Breaking barriers to precision oncology implementation with digital solutions
While precision oncology has shown great promise, there are still barriers to its implementation, such as data fragmentation, staff shortages and time, funding, and lack of…
READ MORE![Hepatocellular carcinoma surveillance and the emerging role of biomarker-based models Screenshot 2023 05 16 190532 Screenshot 2023 05 16 190532](https://clinicalvalue.com/wp-content/uploads/2023/05/Screenshot-2023-05-16-190532-1280x692.jpg)
Hepatocellular carcinoma surveillance and the emerging role of biomarker-based models
A/Prof Simone Strasser recently published an independent commentary in the Australian Medical Research and Journal "Research Review", covering at length topics such as non-alcoholic liver disease…
READ MORE![PIVKA-II: Confidence in HCC surveillance and diagnosis: Prof. Ming-Lung Yu DSC07085 1 DSC07085 1](https://clinicalvalue.com/wp-content/uploads/2023/03/DSC07085-1.png)
PIVKA-II: Confidence in HCC surveillance and diagnosis: Prof. Ming-Lung Yu
In this video, Prof Ming-Lung Yu, Chair Professor of Hepatology at Kaohsiung University Medical Hospital, discusses how PIVKA-II can complement AFP and Ultrasound in assisting clinicians…
READ MORE![Leading the Way for HCC Surveillance and Diagnosis: Dr Bao Toan Nguyen Dr Bao Toan Nguyen combating cancer Dr Bao Toan Nguyen combating cancer](https://clinicalvalue.com/wp-content/uploads/2023/03/Dr-Bao-Toan-Nguyen-combating-cancer-1280x843.jpg)
Leading the Way for HCC Surveillance and Diagnosis: Dr Bao Toan Nguyen
In this video, Dr Bao Toan Nguyen from MEDIC-LAB Ho Chi Minh discusses how PIVKA-II can complement AFP in assisting clinicians in the early detection and…
READ MORE![Liver Disease in Asia Pacific: Insights from Prof Pierce Chow Liver Disease in Asia Pacific Insights from Prof Pierce Chow Liver Disease in Asia Pacific Insights from Prof Pierce Chow](https://clinicalvalue.com/wp-content/uploads/2022/12/Liver-Disease-in-Asia-Pacific_-Insights-from-Prof-Pierce-Chow.jpg)
Liver Disease in Asia Pacific: Insights from Prof Pierce Chow
In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical…
READ MORE![Liver Disease and Patient Advocacy in Taiwan: Q&A with Prof Yang Pei-Ming Liver Disease and Patient Advocacy in Taiwan Q A with Prof Yang Pei Ming Liver Disease and Patient Advocacy in Taiwan Q A with Prof Yang Pei Ming](https://clinicalvalue.com/wp-content/uploads/2022/12/Liver-Disease-and-Patient-Advocacy-in-Taiwan_-Q_A-with-Prof-Yang-Pei-Ming.jpg)
Liver Disease and Patient Advocacy in Taiwan: Q&A with Prof Yang Pei-Ming
Liver disease is a serious public health issue in Taiwan. The Liver Disease Prevention and Treatment Research Foundation, Taiwan, is one of Asia’s most active and…
READ MORE![Liver Cancer in Japan: Dr Shun Kaneko on HCC Screening and Surveillance Liver Cancer in Japan Dr Shun Kaneko on HCC Screening and Surveillance Liver Cancer in Japan Dr Shun Kaneko on HCC Screening and Surveillance](https://clinicalvalue.com/wp-content/uploads/2022/12/Liver-Cancer-in-Japan_-Dr-Shun-Kaneko-on-HCC-Screening-and-Surveillance.jpg)
Liver Cancer in Japan: Dr Shun Kaneko on HCC Screening and Surveillance
Japan is a global leader in hepatocellular carcinoma (HCC) surveillance, with an effective programme that enables early-stage carcinomas detection. Yet unmet needs continue to affect the…
READ MORE![HCC in Thailand: Dr Terachai Songkiatkawin on Improving Liver Cancer Diagnostics and Treatment HCC in Thailand Dr Terachai Songkiatkawin on Improving Liver Cancer Diagnostics and Treatment HCC in Thailand Dr Terachai Songkiatkawin on Improving Liver Cancer Diagnostics and Treatment](https://clinicalvalue.com/wp-content/uploads/2022/12/HCC-in-Thailand_-Dr-Terachai-Songkiatkawin-on-Improving-Liver-Cancer-Diagnostics-and-Treatment.jpg)
HCC in Thailand: Dr Terachai Songkiatkawin on Improving Liver Cancer Diagnostics and Treatment
More than 27,000 patients in Thailand are found to have liver cancer each year, making it the most-frequently diagnosed cancer in the country. With emerging risk…
READ MORE![Tackling HCV in Punjab: local experts share strategies for success Tackling HCV in Punjab local experts share strategies for success Tackling HCV in Punjab local experts share strategies for success](https://clinicalvalue.com/wp-content/uploads/2022/12/Tackling-HCV-in-Punjab_-local-experts-share-strategies-for-success.png)
Tackling HCV in Punjab: local experts share strategies for success
Punjab is one of Pakistan’s largest provinces and has a particularly high HCV prevalence rate of roughly 9%, compared to 5.4% for Pakistan’s total population. Hear…
READ MORE![Strengthening healthcare systems through the critical role of diagnostics Strengthening healthcare systems through the critical role of diagnostics Strengthening healthcare systems through the critical role of diagnostics](https://clinicalvalue.com/wp-content/uploads/2022/12/Strengthening-healthcare-systems-through-the-critical-role-of-diagnostics.jpg)
Strengthening healthcare systems through the critical role of diagnostics
In line with the WHO Essential Diagnostics List (EDL) and Lancet Commission efforts, the Asia Pacific Medical Technology Association and its members recently came together to…
READ MORE![Pakistan’s national HCV elimination programme: insights from Dr Huma Qureshi Pakistans national HCV elimination programme insights from Dr Huma Qureshi Pakistans national HCV elimination programme insights from Dr Huma Qureshi](https://clinicalvalue.com/wp-content/uploads/2022/12/Pakistans-national-HCV-elimination-programme_-insights-from-Dr-Huma-Qureshi.jpg)
Pakistan’s national HCV elimination programme: insights from Dr Huma Qureshi
In 2019, Pakistan announced a nationwide programme to scale up HCV prevention, testing and treatment. Hear from gastroenterologist Dr Huma Qureshi, a key figure in Pakistan’s…
READ MORE![Hepatitis C: the patient journey from screening to diagnosis and treatment Hepatitis C the patient journey from screening to diagnosis and treatment 1 Hepatitis C the patient journey from screening to diagnosis and treatment 1](https://clinicalvalue.com/wp-content/uploads/2022/12/Hepatitis-C_-the-patient-journey-from-screening-to-diagnosis-and-treatment-1.jpg)
Hepatitis C: the patient journey from screening to diagnosis and treatment
An estimated 71 million people around the world are chronically infected with hepatitis C virus (HCV), with a large proportion currently being undiagnosed or diagnosed late.…
READ MORE![HCV screening in Egypt: key elements of a successful national screening programme HCV screening in Egypt key elements of a successful national screening programme 1 HCV screening in Egypt key elements of a successful national screening programme 1](https://clinicalvalue.com/wp-content/uploads/2022/12/HCV-screening-in-Egypt_-key-elements-of-a-successful-national-screening-programme-1.jpg)
HCV screening in Egypt: key elements of a successful national screening programme
In 2018, the world’s largest HCV screening campaign was initiated in Egypt. Within 7 months following its initiation, 49.5 million people were screened; and 2.2 million…
READ MORE![HCV elimination in Sindh: insights from Prof Muhammad Sadik Memon and Dr Zaigham Abbas HCV screening in Egypt key elements of a successful national screening programme HCV screening in Egypt key elements of a successful national screening programme](https://clinicalvalue.com/wp-content/uploads/2022/12/HCV-screening-in-Egypt_-key-elements-of-a-successful-national-screening-programme.jpg)
HCV elimination in Sindh: insights from Prof Muhammad Sadik Memon and Dr Zaigham Abbas
The province of Sindh has one of the world’s highest rates of HCV infection and bears the second highest disease burden of both HBV and HCV…
READ MORE![HCV elimination in Pakistan: insights from Dr Zaigham Abbas HCV elimination in Pakistan insights from Dr Zaigham Abbas HCV elimination in Pakistan insights from Dr Zaigham Abbas](https://clinicalvalue.com/wp-content/uploads/2022/12/HCV-elimination-in-Pakistan_-insights-from-Dr-Zaigham-Abbas.jpg)
HCV elimination in Pakistan: insights from Dr Zaigham Abbas
Pakistan has one of the world’s highest rates of HCV infection. Learn from Dr Zaigham Abbas, Head of Gastroenterology at Ziauddin University Hospital and President of…
READ MORE![HCV elimination in Northern Pakistan: Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands HCV elimination in Northern Pakistan Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands HCV elimination in Northern Pakistan Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands](https://clinicalvalue.com/wp-content/uploads/2022/12/HCV-elimination-in-Northern-Pakistan_-Prof-Aamir-Khan-on-treating-patients-in-KPK-province-and-the-Afghan-borderlands.jpg)
HCV elimination in Northern Pakistan: Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands
Pakistan has one of the world’s highest rates of HCV infection. It's no surprise that their healthcare systems face mounting pressure from HCV-related conditions. Learn from…
READ MORE![Future therapies for chronic Hepatitis B and the role of diagnostics Future therapies for chronic Hepatitis B and the role of diagnostics Future therapies for chronic Hepatitis B and the role of diagnostics](https://clinicalvalue.com/wp-content/uploads/2022/12/Future-therapies-for-chronic-Hepatitis-B-and-the-role-of-diagnostics.jpg)
Future therapies for chronic Hepatitis B and the role of diagnostics
Hepatitis B is an important infectious disease problem in the APAC region. Learn from Prof Henry Chan, director of the Center for Liver Health at Chinese…
READ MORE